Search all trials

Find therapies in clinical trials near you – page 31

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Small cell lung cancer recurrent

Not recruiting

Registered drugNo placebo

Study comparing tarlatamab with topotecan in patients with relapsed small cell lung cancer after first-line chemotherapy

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Ammonium Chloride

Contact Research Centre

Malignant melanoma

Not recruiting

Registered drugNo placebo

Study Comparing MK-7684A (Vibostolimab and Pembrolizumab) with Pembrolizumab for Adults and Children with High-Risk Stage II-IV Melanoma

Registered drugNo placebo

Italy

Participants:0–17 years · 18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Early onset familial Alzheimer's disease

Not recruiting

Investigational

Study on the Safety and Effects of ABBV-916 and MK-6240 for Patients with Early Alzheimer's Disease

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Florquinitau (18F)

Contact Research Centre

Primary biliary cholangitis

Not recruiting

Investigational

Study on Volixibat for Treating Itching in Patients with Primary Biliary Cholangitis

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Volixibat

Contact Research Centre

Hepatic encephalopathy

Not recruiting

Investigational

Study on Rifaximin for Delaying Hepatic Encephalopathy in Cirrhosis Patients

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Rifaximin

Contact Research Centre

Gastrointestinal stromal tumour

Not recruiting

Registered drugNo placebo

Study of Ripretinib vs Sunitinib for Patients with Advanced Gastrointestinal Stromal Tumor with Specific KIT Exon Mutations Previously Treated with Imatinib

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Ripretinib

Contact Research Centre

Metabolic dysfunction-associated steatohepatitis+1

Not recruiting

Registered drug

Study on Efinopegdutide and Semaglutide for Adults with Non-Alcoholic Steatohepatitis (NASH) Before Cirrhosis

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Efinopegdutide

Contact Research Centre

Primary biliary cholangitis+1

Not recruiting

InvestigationalNo placebo

Study on Long-term Safety of Linerixibat for Treating Itchy Skin in Patients with Primary Biliary Cholangitis

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Linerixibat

Contact Research Centre

Bronchiectasis

Not recruiting

Registered drug

Study on Long-Term Safety and Efficacy of BI 1291583 in Patients with Bronchiectasis

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Bi 1291583

Contact Research Centre

Study on Langerhans Cell Histiocytosis Treatment in Children and Adolescents Using Cladribine, Prednisolone, and Cytarabine

Not recruiting

Registered drugNo placebo

Study on Langerhans Cell Histiocytosis Treatment in Children and Adolescents Using Cladribine, Prednisolone, and Cytarabine

Registered drugNo placebo

Italy

Participants:0–17 years
Substances:Alemtuzumab

Contact Research Centre

Cholestatic pruritus

Not recruiting

Investigational

Study on Maralixibat Chloride for Treating Itchy Skin in Patients with Cholestatic Pruritus

Investigational

Italy

Participants:0–17 years · 18–64 years · 65+ years
Substances:Maralixibat Chloride

Contact Research Centre

Primary biliary cholangitis

Not recruiting

Investigational

Study on Golexanolone for Patients with Primary Biliary Cholangitis Experiencing Fatigue and Cognitive Dysfunction

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Golexanolone

Contact Research Centre

Find therapies in clinical trials near you – page 31

380 trials match your criteria

Small cell lung cancer recurrent

Study comparing tarlatamab with topotecan in patients with relapsed small cell lung cancer after first-line chemotherapy

Malignant melanoma

Study Comparing MK-7684A (Vibostolimab and Pembrolizumab) with Pembrolizumab for Adults and Children with High-Risk Stage II-IV Melanoma

Early onset familial Alzheimer's disease

Study on the Safety and Effects of ABBV-916 and MK-6240 for Patients with Early Alzheimer's Disease

Primary biliary cholangitis

Study on Volixibat for Treating Itching in Patients with Primary Biliary Cholangitis

Hepatic encephalopathy

Study on Rifaximin for Delaying Hepatic Encephalopathy in Cirrhosis Patients

Gastrointestinal stromal tumour

Study of Ripretinib vs Sunitinib for Patients with Advanced Gastrointestinal Stromal Tumor with Specific KIT Exon Mutations Previously Treated with Imatinib

Metabolic dysfunction-associated steatohepatitis+1

Study on Efinopegdutide and Semaglutide for Adults with Non-Alcoholic Steatohepatitis (NASH) Before Cirrhosis

Primary biliary cholangitis+1

Study on Long-term Safety of Linerixibat for Treating Itchy Skin in Patients with Primary Biliary Cholangitis

Bronchiectasis

Study on Long-Term Safety and Efficacy of BI 1291583 in Patients with Bronchiectasis

Study on Langerhans Cell Histiocytosis Treatment in Children and Adolescents Using Cladribine, Prednisolone, and Cytarabine

Study on Langerhans Cell Histiocytosis Treatment in Children and Adolescents Using Cladribine, Prednisolone, and Cytarabine

Cholestatic pruritus

Study on Maralixibat Chloride for Treating Itchy Skin in Patients with Cholestatic Pruritus

Primary biliary cholangitis

Study on Golexanolone for Patients with Primary Biliary Cholangitis Experiencing Fatigue and Cognitive Dysfunction

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.